sarpogrelate has been researched along with Diabetic Angiopathies in 7 studies
sarpogrelate: structure given in first source
Diabetic Angiopathies: VASCULAR DISEASES that are associated with DIABETES MELLITUS.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The aim was to evaluate the significance of arteriosclerosis obliterans-related biomarkers in patients with type 2 diabetes mellitus (T2DM), and to compare the effects of sarpogrelate, eicosapentaenoic acid (EPA) and pitavastatin on these markers." | 5.27 | Effects of sarpogrelate, eicosapentaenoic acid and pitavastatin on arterioslcerosis obliterans-related biomarkers in patients with type 2 diabetes (SAREPITASO study). ( Ito, T; Nomura, S; Okuda, Y; Omoto, S; Shouzu, A; Suzuki, M; Taniura, T, 2018) |
| "The combined treatment of sustained-release basic fibroblast growth factor (Sr-bFGF) and a 5-hydroxytryptamine(2A) blocker, sarpogrelate, was evaluated to see whether it reversed the impaired collateral circulation in diabetic (DM) mouse hindlimb ischemia." | 3.74 | New therapeutic approach for impaired arteriogenesis in diabetic mouse hindlimb ischemia. ( Arai, Y; Bir, SC; Esaki, J; Fujita, M; Hirose, K; Huang, Y; Ikeda, T; Komeda, M; Marui, A; Sakaguchi, H; Tabata, Y, 2008) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (28.57) | 29.6817 |
| 2010's | 5 (71.43) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Nomura, S | 2 |
| Taniura, T | 1 |
| Shouzu, A | 2 |
| Omoto, S | 2 |
| Suzuki, M | 1 |
| Okuda, Y | 1 |
| Ito, T | 1 |
| Yoo, H | 1 |
| Park, I | 1 |
| Kim, DJ | 1 |
| Lee, S | 1 |
| Nagayama, D | 1 |
| Ohira, M | 1 |
| Saiki, A | 1 |
| Shirai, K | 1 |
| Tatsuno, I | 1 |
| Iwabayashi, M | 1 |
| Taniyama, Y | 1 |
| Sanada, F | 1 |
| Azuma, J | 1 |
| Iekushi, K | 1 |
| Kusunoki, H | 1 |
| Chatterjee, A | 1 |
| Okayama, K | 1 |
| Rakugi, H | 1 |
| Morishita, R | 1 |
| Park, SY | 1 |
| Rhee, SY | 1 |
| Oh, S | 1 |
| Kwon, HS | 1 |
| Cha, BY | 1 |
| Lee, HJ | 1 |
| Lee, HC | 1 |
| Kim, YS | 1 |
| Nishikawa, M | 1 |
| Iwasaka, T | 1 |
| Bir, SC | 1 |
| Fujita, M | 1 |
| Marui, A | 1 |
| Hirose, K | 1 |
| Arai, Y | 1 |
| Sakaguchi, H | 1 |
| Huang, Y | 1 |
| Esaki, J | 1 |
| Ikeda, T | 1 |
| Tabata, Y | 1 |
| Komeda, M | 1 |
2 trials available for sarpogrelate and Diabetic Angiopathies
| Article | Year |
|---|---|
Effects of sarpogrelate, eicosapentaenoic acid and pitavastatin on arterioslcerosis obliterans-related biomarkers in patients with type 2 diabetes (SAREPITASO study).
Topics: Adiponectin; Aged; Aged, 80 and over; Ankle Brachial Index; Arteriosclerosis Obliterans; Biomarkers; | 2018 |
Evaluation of the effectiveness of sarpogrelate on the surrogate markers for macrovascular complications in patients with type 2 diabetes.
Topics: Adiponectin; Adult; Aged; Ankle Brachial Index; Aspirin; Biomarkers; C-Reactive Protein; Carotid Int | 2012 |
5 other studies available for sarpogrelate and Diabetic Angiopathies
| Article | Year |
|---|---|
Effects of sarpogrelate on microvascular complications with type 2 diabetes.
Topics: Aged; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Diabetic Nephropathies; Diabetic Neuropathie | 2019 |
Sarpogrelate hydrochloride decreases cardio-ankle vascular index accompanied by increased serum lipoprotein lipase mass in type 2 diabetic patients.
Topics: Aged; Ankle Brachial Index; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Dose-Response Relation | 2014 |
Role of serotonin in angiogenesis: induction of angiogenesis by sarpogrelate via endothelial 5-HT1B/Akt/eNOS pathway in diabetic mice.
Topics: Angiogenesis Inducing Agents; Animals; Cells, Cultured; Diabetes Mellitus, Experimental; Diabetic An | 2012 |
5-HT2A receptor antagonist increases circulating adiponectin in patients with type 2 diabetes.
Topics: Adiponectin; Biomarkers; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Endothelium, Vascular; Fe | 2005 |
New therapeutic approach for impaired arteriogenesis in diabetic mouse hindlimb ischemia.
Topics: Animals; Base Sequence; Collateral Circulation; Delayed-Action Preparations; Diabetes Mellitus, Expe | 2008 |